|
TM7SF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.484400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.919800E-01 |
| Normal-vs-Stage2 |
7.252200E-02 |
| Normal-vs-Stage3 |
9.838900E-03 |
| Normal-vs-Stage4 |
2.010400E-04 |
| Stage1-vs-Stage2 |
2.287000E-01 |
| Stage1-vs-Stage3 |
2.236200E-02 |
| Stage1-vs-Stage4 |
4.603700E-04 |
| Stage2-vs-Stage3 |
6.321800E-01 |
| Stage2-vs-Stage4 |
1.025570E-01 |
| Stage3-vs-Stage4 |
1.622390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.354000E-02 |
| Normal-vs-AfricanAmerican |
1.651980E-01 |
| Normal-vs-Asian |
8.019800E-01 |
| Caucasian-vs-AfricanAmerican |
9.525600E-01 |
| Caucasian-vs-Asian |
5.735800E-01 |
| AfricanAmerican-vs-Asian |
6.809800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.903100E-03 |
| Normal-vs-Female |
5.545200E-01 |
| Male-vs-Female |
1.381330E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.584900E-04 |
| Normal-vs-Age(41-60Yrs) |
8.540300E-02 |
| Normal-vs-Age(61-80Yrs) |
4.559500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.074800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.805800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.626300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.663600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.293600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.437000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.291800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.385200E-01 |
| Normal-vs-Grade 2 |
3.901600E-01 |
| Normal-vs-Grade 3 |
5.931700E-02 |
| Normal-vs-Grade 4 |
3.87980000016164E-07 |
| Grade 1-vs-Grade 2 |
3.812200E-01 |
| Grade 1-vs-Grade 3 |
1.806200E-01 |
| Grade 1-vs-Grade 4 |
1.461470E-03 |
| Grade 2-vs-Grade 3 |
1.251800E-01 |
| Grade 2-vs-Grade 4 |
5.05479999968195E-07 |
| Grade 3-vs-Grade 4 |
3.783700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.621410E-01 |
| Normal-vs-ccB subtype |
2.30279999999805E-05 |
| ccA subtype-vs-ccB subtype |
6.70574706873595E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.444420E-01 |
| Normal-vs-N1 |
8.629800E-02 |
| N0-vs-N1 |
3.816600E-01 |
|
|
